02.13.24 -- FDA Issues Draft Guidance For Cell & Gene Therapy Potency Assurance

The FDA recently released a draft guidance, Potency Assurance for Cellular and Gene Therapy Products. This article summarizes the draft guidance. The public comment period ends March 27, 2024.

Here's a high-level summary of what is increasingly becoming an essential part of the downstream bioprocessing production line.